Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00829387 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy for Diabetic Neuropathic Pain

A NA study, sponsored by VA Connecticut Healthcare System.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT00829387: Completed NA study, sponsored by VA Connecticut Healthcare System.

NCT00829387 is a NA study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00829387, a NA study, has completed, sponsored by VA Connecticut Healthcare System.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy of a brief psychological intervention, cognitive-behavior therapy, for the management of persistent pain associated with diabetic peripheral neuropathic pain.

Interventions

  • BEHAVIORAL CBT plus standard pharmaceutical care (CBT/SC)
  • BEHAVIORAL Diabetic Education plus standard pharmaceutical care (ED/SC)

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2010-03
Est. Completion 2013-12
Phase NA

Sponsor

VA Connecticut Healthcare System

26 total trials

What the Registry Record Tells You About NCT00829387

The ClinicalTrials.gov registry entry for NCT00829387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which CBT plus standard pharmaceutical care (CBT/SC) is the first listed.

NCT00829387 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00829387 about?

NCT00829387 is a clinical study titled "Cognitive Behavioral Therapy for Diabetic Neuropathic Pain". The purpose of this study is to evaluate the efficacy of a brief psychological intervention, cognitive-behavior therapy, for the management of persistent pain associated with diabetic peripheral neuropathic pain.

What is the current status of trial NCT00829387?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2010-03. Estimated completion is 2013-12.

What interventions are being tested in trial NCT00829387?

The interventions under investigation include: CBT plus standard pharmaceutical care (CBT/SC) (BEHAVIORAL), Diabetic Education plus standard pharmaceutical care (ED/SC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00829387?

This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.